Literature DB >> 10956257

Leukocyte-endothelial cell interactions in diabetic retina after transient retinal ischemia.

A Tsujikawa1, J Kiryu, A Nonaka, K Yamashiro, H Nishiwaki, Y Honda, Y Ogura.   

Abstract

Diabetes is associated with increased neural damage after transient cerebral ischemia. Recently, leukocytes, which are thought to play a central role in ischemia-reperfusion injury, have been suggested to be involved in exacerbated damage after transient ischemia in diabetic animals. The present study was designed to clarify whether the anticipated worse outcome after transient cerebral ischemia in diabetic animals was due to augmented leukocyte-mediated neural injury. Using rats with streptozotocin-induced diabetes of 4-wk duration, we investigated leukocyte-endothelial cell interactions during reperfusion after a transient 60-min period of retinal ischemia. Unexpectedly, postischemic diabetic retina showed no active leukocyte-endothelial cell interactions during reperfusion. The maximal numbers of rolling and accumulating leukocytes in diabetic retina were reduced by 73.6 and 41.2%, respectively, compared with those in nondiabetic rats. In addition, neither preischemic insulin treatment of diabetic rats nor preischemic glucose infusion of nondiabetic rats significantly influenced leukocyte-endothelial cell interactions during reperfusion. The present study demonstrated that high blood glucose concentration before induction of ischemia did not exacerbate leukocyte involvement in the postischemic retinal injury. Furthermore, diabetic retina showed suppressed leukocyte-endothelial cells interactions after transient ischemia, perhaps due to an adaptive mechanism that developed during the period of induced diabetes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10956257     DOI: 10.1152/ajpregu.2000.279.3.R980

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  3 in total

1.  In vivo evaluation of ocular inflammatory responses in experimental diabetes.

Authors:  H Tamura; J Kiryu; K Miyamoto; K Nishijima; H Katsuta; S Miyahara; F Hirose; Y Honda; N Yoshimura
Journal:  Br J Ophthalmol       Date:  2005-08       Impact factor: 4.638

2.  Surface engineering of quantum dots for in vivo vascular imaging.

Authors:  Ashwath Jayagopal; Patricia K Russ; Frederick R Haselton
Journal:  Bioconjug Chem       Date:  2007-08-31       Impact factor: 4.774

3.  SIRT1 inhibition during the hypoinflammatory phenotype of sepsis enhances immunity and improves outcome.

Authors:  Vidula T Vachharajani; Tiefu Liu; Candice M Brown; Xianfeng Wang; Nancy L Buechler; Jonathan David Wells; Barbara K Yoza; Charles E McCall
Journal:  J Leukoc Biol       Date:  2014-07-07       Impact factor: 4.962

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.